Sanofi wins EU approval for Wayrilz to treat immune thrombocytopenia
Go back to Sanofi wins EU approval for Wayrilz to treat immune thrombocytopenia| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.26 -0.16 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.42 | 52 Week High | $5.58 | |||
| Open | $14.23 | 52 Week Low | $3.60 | |||
| Day High | $14.38 | P/E | N/A | |||
| Day Low | $14.14 | EPS | $0.00 | |||
| Volume | 6,735,170 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 41.18 +0.07 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.11 | 52 Week High | $44.76 | |||
| Open | $40.78 | 52 Week Low | $36.81 | |||
| Day High | $41.24 | P/E | N/A | |||
| Day Low | $40.77 | EPS | $0.00 | |||
| Volume | 1,586,196 | |||||

